Integrating whole genome sequencing and machine learning for predicting antimicrobial resistance in critical pathogens: a systematic review of antimicrobial susceptibility tests.

Autor: Ardila CM; Basic Sciences Department, Faculty of Dentistry, Universidad de Antioquia, Medellin, Colombia.; CIFE University Center, Cuernavaca, Mexico., Yadalam PK; Periodontics, Saveetha University, Saveetha, India., González-Arroyave D; Surgery, Universidad Pontificia Bolivariana, Medellin, Colombia.
Jazyk: angličtina
Zdroj: PeerJ [PeerJ] 2024 Oct 09; Vol. 12, pp. e18213. Date of Electronic Publication: 2024 Oct 09 (Print Publication: 2024).
DOI: 10.7717/peerj.18213
Abstrakt: Background: Infections caused by antibiotic-resistant bacteria pose a major challenge to modern healthcare. This systematic review evaluates the efficacy of machine learning (ML) approaches in predicting antimicrobial resistance (AMR) in critical pathogens (CP), considering Whole Genome Sequencing (WGS) and antimicrobial susceptibility testing (AST).
Methods: The search covered databases including PubMed/MEDLINE, EMBASE, Web of Science, SCOPUS, and SCIELO, from their inception until June 2024. The review protocol was officially registered on PROSPERO (CRD42024543099).
Results: The review included 26 papers, analyzing data from 104,141 microbial samples. Random Forest (RF), XGBoost, and logistic regression (LR) emerged as the top-performing models, with mean Area Under the Receiver Operating Characteristic (AUC) values of 0.89, 0.87, and 0.87, respectively. RF showed superior performance with AUC values ranging from 0.66 to 0.97, while XGBoost and LR showed similar performance with AUC values ranging from 0.83 to 0.91 and 0.76 to 0.96, respectively. Most studies indicate that integrating WGS and AST data into ML models enhances predictive performance, improves antibiotic stewardship, and provides valuable clinical decision support. ML shows significant promise for predicting AMR by integrating WGS and AST data in CP. Standardized guidelines are needed to ensure consistency in future research.
Competing Interests: The authors declare there are no competing interests.
(©2024 Ardila et al.)
Databáze: MEDLINE